Monogram Biosciences Announces Third Quarter 2006 Financial Results Conference Call
2006年10月24日 - 9:57AM
PRニュース・ワイアー (英語)
SOUTH SAN FRANCISCO, Calif., Oct. 23 /PRNewswire-FirstCall/ --
Monogram Biosciences, Inc., (NASDAQ:MGRM) announced that it will
hold a conference call on Thursday, October 26, 2006 at 4:30 p.m.
(Eastern Time) to discuss third quarter 2006 financial results. The
call will be hosted by Mr. William D. Young, Chairman & CEO of
Monogram. To participate in the live teleconference, please call
(800) 817-4887, or (913) 981-4913 for international callers,
fifteen minutes before the conference begins. Live audio of the
call will be simultaneously broadcast over the Internet and will be
available to members of the news media, investors and the general
public. Access to live and archived audio of the conference call
will be available by following the appropriate links at
http://www.monogrambio.com/ and clicking on the Investor Relations
link. Following the live broadcast, a replay of the call will also
be available at (888) 203-1112 or (719) 457-0820 for international
callers, through Friday, November 3, 2006. The replay passcode is
3470325. The information provided on the teleconference is only
accurate at the time of the conference call, and Monogram will take
no responsibility for providing updated information except as
required by law. About Monogram Biosciences, Inc. Monogram is
advancing individualized medicine by discovering, developing and
marketing innovative products to guide and improve treatment of
serious infectious diseases and cancer. The Company's products are
designed to help doctors optimize treatment regimens for their
patients that lead to better outcomes and reduced costs. The
Company's technology is also being used by numerous
biopharmaceutical companies to develop new and improved antiviral
therapeutics and vaccines as well as targeted cancer therapeutics.
More information about the Company and its technology can be found
on its web site at http://www.monogrambio.com/. contacts: Alfred G.
Merriweather Jeremiah Hall Chief Financial Officer Feinstein Kean
Healthcare Tel: 650 624-4576 Tel: 415 677-2700 amerriweather@
jeremiah.hall@ monogrambio.com fkhealth.com DATASOURCE: Monogram
Biosciences, Inc. CONTACT: Alfred G. Merriweather, Chief Financial
Officer of Monogram Biosciences, Inc., +1-650-624-4576, ; or
Jeremiah Hall of Feinstein Kean Healthcare, +1-415-677-2700, Web
site: http://www.monogrambio.com/
Copyright
Monogram Technologies (NASDAQ:MGRM)
過去 株価チャート
から 6 2024 まで 7 2024
Monogram Technologies (NASDAQ:MGRM)
過去 株価チャート
から 7 2023 まで 7 2024